E136Q (p.Glu136Gln) variant of CASQ2 (Calsequestrin-2)
E136Q (p.Glu136Gln) in CASQ2 (Calsequestrin-2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes structural context.
E136Q (p.Glu136Gln) variant details
- p.Glu136Gln
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available